One participant said the psychedelic drug allowed him to see that human suffering could be “transcended and transformed.”
Psilocybin can lift depression in clinicians who worked on COVID-19 frontlines, trial finds
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- US flu season shows signs of peak
- Hospitalized COVID patients at higher risk for organ-related death, readmission for 2.5 years, data suggest
- Liberals’, conservatives’ trust in US government’s use of digital health data diverged during COVID
- Report: COVID survivors nearly twice as likely to have ongoing symptoms as those with flu